Company Data
Thiogenesis Therapeutics Corp.
Ticker
TTI:CA
Current Price
$0.57 7.55%
Market Cap
$39.9M
Price Target
Refer to Report
Volume
3.0K
52wk Range
$0.44 - $0.87
Overview
Thiogenesis Therapeutics Corp is an early stage biotech company. It is developing novel drug formulations that act as precursors to cysteamine, which is a small aminothiol compound that is endogenous in humans in small quantities.